Company attributes
Location
B2X
0
Pitchbook URL
Legal Name
AM-Pharma B.V.
Number of Employees (Ranges)
11 – 500
Email Address
info@am-pharma.com
Phone Number
+31302289222
Number of Employees
40
Full Address
Stadsplateau 6, Utrecht, NL
Investors
Founded Date
2002
Total Funding Amount (USD)
302,843,400
Latest Funding Round Date
July 16, 2019
Latest Funding Type
Patents Assigned (Count)
5
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
130,000,000
Public/Private
Private
Previously, the company developed and tested a bovine form of AP in three phase II trials in patients with sepsis, AKI and UC.AM-Pharma has since developed and manufactured a proprietary and fully human recombinant form of AP, known as recAP.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.